Oncology Pharma Inc. (ONPH)
OTCMKTS · Delayed Price · Currency is USD
0.0040
0.00 (0.00%)
At close: Dec 12, 2025
Oncology Pharma Market Cap
Oncology Pharma has a market cap or net worth of $154.65 thousand as of December 12, 2025. Its market cap has increased by 3,900.34% in one year.
Market Cap
154.65K
Enterprise Value
n/a
Revenue
10.21K
Ranking
n/a
PE Ratio
0.83
Stock Price
$0.00
Market Cap Chart
Since April 1, 2016, Oncology Pharma's market cap has increased from 27.10K to 154.65K, an increase of 470.68%. That is a compound annual growth rate of 19.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 154.65K | 3,900.34% |
| Dec 31, 2024 | 3.87K | -50.01% |
| Dec 29, 2023 | 7.73K | -99.94% |
| Dec 30, 2022 | 13.06M | -90.45% |
| Dec 31, 2021 | 136.74M | 1,159.48% |
| Dec 31, 2020 | 10.86M | 312.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Apr 1, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 832.80M |
| Elite Pharmaceuticals | 557.48M |
| Glass House Brands | 465.38M |
| CytoDyn | 413.07M |
| American Oncology Network | 365.47M |
| Northwest Biotherapeutics | 363.26M |
| Silence Therapeutics | 295.68M |
| Nika Pharmaceuticals | 290.99M |